Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Total Non-Current Liabilities (2021 - 2025)

Rxo's Total Non-Current Liabilities history spans 5 years, with the latest figure at $698.0 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 5.29% year-over-year to $698.0 million; the TTM value through Dec 2025 reached $698.0 million, down 5.29%, while the annual FY2025 figure was $698.0 million, 5.29% down from the prior year.
  • Total Non-Current Liabilities reached $698.0 million in Q4 2025 per RXO's latest filing, down from $714.0 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $793.0 million in Q3 2024 to a low of $182.0 million in Q4 2021.
  • Average Total Non-Current Liabilities over 5 years is $597.7 million, with a median of $624.0 million recorded in 2023.
  • Peak YoY movement for Total Non-Current Liabilities: skyrocketed 241.21% in 2022, then decreased 11.59% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $182.0 million in 2021, then surged by 241.21% to $621.0 million in 2022, then fell by 11.59% to $549.0 million in 2023, then soared by 34.24% to $737.0 million in 2024, then fell by 5.29% to $698.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Total Non-Current Liabilities are $698.0 million (Q4 2025), $714.0 million (Q3 2025), and $733.0 million (Q2 2025).